期刊文献+

中间高血糖与微血管并发症 被引量:1

Microvascular Complications and Intermediate Hyperglycemia
下载PDF
导出
摘要 中间高血糖(IHG)是介于正常与糖尿病之间的血糖段,包括空腹血糖受损(IFG)与糖耐量低减(IGT)。新近发现IHG的大血管的疾病的死亡事件危险增加,其中IGT对心血管疾病的死亡危险比IFG更具有预见性,而且IFG与IGT也与类似传统的糖尿病并发症包括肾、视网膜与神经等微血管并发症独立相关,认为其机制与代谢综合征的各种因子如高血脂、胰岛素抵抗及高血糖等导致的血管内皮功能障碍有关。对中间高血糖的人群进行严格的饮食、运动的干预比药物的治疗更有效。 Intermediate hyperglycemia(IHG) is defined as concentration of blood glucose between normo- glycemia and diabetes mellitus including impaired fasting glucose(IFG) and impaired glucose tolerance (IGT). It is found that patients with IHG had high risk of death and morbidity resulting from cardiovascular. And IGT is more better than IFG in predicting cardiovascular morbidity. [HG is also independently associated with microvascular complications that similar to traditional diabetic complications including renal disease, retinopathy, and polyneuropathy. The mechanism is considered to be related to endothelial functional disturbance resuhing from many factors in metabolic syndrome, such as hyperlipidemia, insulin resistance, and, hyperglycemia and so on.. Modifications of diet and exercise is more effective than drug treatment, for patients IHG in preventing early mierovascular complications.
作者 吕以培
出处 《医学综述》 2008年第24期3752-3755,共4页 Medical Recapitulate
基金 广西自然科学基金(桂科攻0816004-26)
关键词 中间高血糖 微血管并发症 内皮功能障碍 Intermediate hyperglycemia Mierovaseular complications Endothelial dysfunction
  • 相关文献

参考文献11

二级参考文献54

  • 1陈树春,宋光耀,刘殿武,叶蔚,马慧娟,马博清,刘铁迎,霍丽梅,魏立民.2型糖尿病的非糖尿病一级亲属的血管内皮功能受损[J].中华内分泌代谢杂志,2004,20(4):329-330. 被引量:10
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3唐朝枢,谢选珠,李兆萍,李春英,宋宗恩,邵磊,汤健,苏静怡.内皮素在休克中的发病学意义[J].生理学报,1989,41(5):489-496. 被引量:51
  • 4田慧,潘长玉,陆菊明,孔祥涛,陆小平,姚晨,蒋赐恩,邓心新,王淑玉,朱艳,崔岚,王正升.糖代谢异常人群中冠心病、高血压的患病率及危险因素调查[J].中华内科杂志,1996,35(5):306-309. 被引量:18
  • 5Dandona P, Mohanty P , Chaudhuri A , et al. Insulin infusion in acute illness.J Clin Invest 2005,115(8):2069-2072.
  • 6Wellen KE and Hotamisligil G S. Inflammation, stress, and diabetes .J Clin Invest 2005 115:1111 - 1119.
  • 7Hansson G. K . Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med 2005,352:1685 - 1695.
  • 8H. Bruunsgaard. Physical activity and modulation of systemic low- level inflammation. J Leukoc Biol 2005,78(4) :819 -835.
  • 9Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin the rapy protects the endothelium of critically ill patients. J Clin Invest 2005,115:277- 228.6.
  • 10Aljada A, Saadeh R, Ghanim H, et al. Insulin inhibits Nfkappa B and MCP-1 expression in human aortic endothelial cells.J Clin Endocrinol Metab 2001,86:450-453.

共引文献127

同被引文献19

  • 1程莹,潘长玉.糖尿病和中间高血糖的定义和诊断(WHO/IDF评议报告)[J].中华内分泌代谢杂志,2006,22(6). 被引量:63
  • 2Futterman LG, Lemberg L. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events[ J ]. Am J Crit Care, 21302,11(5):482-486.
  • 3Klausen KP, Scharling H, Jensen JS. Very low level of microalbu- minuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases [ J ]. J Intern Med, 2006,260 ( 3 ) : 231-237.
  • 4Marsden PA, Dorfman DM, Collins T, et al. Regulated expression of endothelin 1 in glomemlar capillary endothelial cells[ J]. Am J Physiol, 1991,261 (1Pt2) :Fl17-125.
  • 5Yang Z, Xing X, Xiao J, et al. Prevalence of cardiovascular dis- ease and risk factors in the Chinese population with impaired glu- cose regulation: the 2007-2008 China national diabetes and meta- bolic disorders study [ J ]. Exp Clin Endocrinol Diabetes, 2013, 121 (6) :372-374.
  • 6Hsieh SD, Muto T. The superiority of waist-to-height ratio as an anthropometrie index to evaluate clustering of coronary risk factors among non-obese men and women [ J ]. Prev Med, 2005,40 ( 2 ) : 216 -220.
  • 7Muffs DM, Houben AJ, Schram MT, et al. Microvascular dysfunc- tion : an emerging pathway in the pathogenesis of obesity-related in- sulin resistance[J]. Rev Endoer Metab Disord, 2013,14( 1 ) :29- 38.
  • 8Pfieto D, Contreras C, SOnchez A. Endothelial dysfunction, obesi- ty and insulin resistance [ J ]. Curt Vasc Pharmacol, 2014, 1 2 ( 3 ) : 412-426.
  • 9Iantomo M, Carnpia U, Daniele N, et al. Obesity, inflammation and endothelial dysfunction [ J ]. J Biol Regul Homeost Agents, 2014,28(2) :169-176.
  • 10Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insu- lin secretion, and insulin sensitivity in nonobese and obese Japa- nese subjects[J]. Diabetes Care, 1997,20(10) :1562-1568.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部